Healthcare IT Integration Market by Product & Services, Application and Forecast to 2024

Healthcare IT integration is a consortium of IT and healthcare sector and involves the application of latest IT solutions to monitor people’s health, perform secured exchange of their electronic data and provide economical healthcare solutions. The application of IT in other domains has presented positive outcomes and the same is expected in terms of healthcare. The global healthcare IT integration market is estimated to witness a considerable growth during the forecast period. The major factors that will accelerate the growth of the healthcare IT integration market are high healthcare costs, government initiatives to curb this rising cost and the growing demand to incorporate IT in the healthcare domain. However, the cost of incorporation is expensive and needs to monitored for the growth in the global market.



The players in the global market are focusing to launch products with technological advancements which is causing rapid growth of the market. Another key factor that drives the growth of the healthcare IT integration market is the integration of healthcare industry with information technology and application of IoT (Internet of Things) to curb the overall healthcare cost. The government organizations have been providing their support and taking initiatives for the growth of the healthcare integration market size. The exchange of patient’s clinical data among hospitals and their partners, provides solutions for complex interoperability challenges and further supports the market growth.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/healthcare-it-integration-market/report-sample

Globally, North America leads the healthcare IT integration market followed by Europe. The reasons for the growth of North America healthcare IT integration industry are technologically advanced environment in the region, increased government intervention to provide better healthcare facilities and favorable reimbursement policies that aid in lowering the rising healthcare cost and the growing demand of integrating IT into the healthcare system. Additionally, as per the World Bank statistics, North America aging population (>65) has witnessed a considerable growth from 12% in 2013 to 15% in 2016, consequently increase in prevalence of age related diseases is also expected, which requires focus on the overall health condition of the individual. Further, the presence of large players in the North America market also adds to their subsequent growth in the global market.

Some of the key players in the global healthcare IT integration market are Quality Systems Inc., Allscripts Healthcare Solutions, Inc., Orion Health, Oracle Corporation, Qualcomm Life, Inc., IBM Corporation, Corepoint Health LLC, GE Healthcare, Siemens Health, Epic Systems Corporation, Summit Healthcare Services, Inc.

Blood Group Typing Market Overview, Share and Forecast Report 2024

Blood group typing is a procedure of determining what specific type of blood a person has, which depends on the presence of antigens on the red blood cells. It is done in organ donation process, to safely donate or receive a blood transfusion and to determine whether Rh factor is present on the surface of the red blood cell. Blood group typing is very important during pregnancy as it can prevent severe anaemia in the new born. There are various techniques and methods to detect the blood group. The global blood group typing market has witnessed significant growth due to the advancement in technology which has improved detection methods.



Globally, the demand for blood group typing products and services was largest in hospitals due to the increasing awareness regarding the importance of blood donations and growth in the requirements of blood for surgical treatments. Other key end users in the global blood group typing market are clinical laboratories and blood banks.

The global blood group typing market is expected to grow significantly during the forecast period. The major driving force behind this growth are the increase in the use of blood group typing in forensic science; need for grouping of the blood during pregnancy and prenatal testing; growth in the number of road accidents and trauma cases that requires blood transfusion; increase in the demand of blood and blood products; and rise in blood donation. Blood group typing is very crucial for the detection of hemolytic disease of the newborn (HDN) in pregnant women which eventually stimulates the usage of blood group typing, hence causing the growth of the global market.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=blood-group-typing-market

North America held the largest share in the global blood group typing market in 2016, followed by Europe. It was the prominent market for the blood group typing products and services. The reasons of the dominance of North America is the presence of different reimbursement schemes for several surgeries and prevalence of chronic diseases. Asia-Pacific blood group typing market is expected to witness the fastest growth during the forecast period with the growth centered at China, Japan, and India.

They key players in the global blood group typing market are Bio-Rad Laboratories, Inc., Immucor, Inc., Quotient Limited, BAG Health Care GmbH, DAY medical SA, Grifols S.A., Ortho Clinical Diagnostics, Inc., Novacyt Group, DIAGAST, AXO Science, and Agena Bioscience, Inc.

Blood Group Typing Market Analysis, Share and Forecast Report 2024

Blood group typing is a procedure of determining what specific type of blood a person has, which depends on the presence of antigens on the red blood cells. It is done in organ donation process, to safely donate or receive a blood transfusion and to determine whether Rh factor is present on the surface of the red blood cell. Blood group typing is very important during pregnancy as it can prevent severe anaemia in the new born. There are various techniques and methods to detect the blood group. The global blood group typing market has witnessed significant growth due to the advancement in technology which has improved detection methods.



The global blood group typing market is categorized on the basis of the product and service offerings; techniques used; type of tests; and its end users. Based on product and services, the global market is segmented into consumables, instruments and services. Consumable, which includes blood bank saline, anti-human globulin reagents, antisera reagents and red blood cells reagents, held largest share in the global blood typing market in 2016. It has major contribution towards the growth of the global group typing market as compared to other segments. The major factor driving this growth are increasing rate of blood donation and major surgical procedures like organ transplantation.

Globally, the demand for blood group typing products and services was largest in hospitals due to the increasing awareness regarding the importance of blood donations and growth in the requirements of blood for surgical treatments. Other key end users in the global blood group typing market are clinical laboratories and blood banks.

Regulatory standards for the blood transfusion are stringent as it is a very crucial process. Stringent regulatory requirements hinder the growth of the global blood group typing market. Other key factor restraining the growth of the global market is lack of trained and skilled professionals which can cause misleading transfusion.

They key players in the global blood group typing market are Bio-Rad Laboratories, Inc., Immucor, Inc., Quotient Limited, BAG Health Care GmbH, DAY medical SA, Grifols S.A., Ortho Clinical Diagnostics, Inc., Novacyt Group, DIAGAST, AXO Science, and Agena Bioscience, Inc.

Stem Cell Banking Market - Business Strategies and Opportunities with Key Players Analysis

Stem cells are the cells that have the potential to differentiate into various types of cells in the body. Embryonic stem cells and adult stem cells are the two main types of stem cells. Stem cells could possibly be used to generate cells and tissues for therapy of a variety of diseases including Alzheimer's disease, Parkinson's disease, heart disease, spinal cord injury, diabetes, and arthritis. The global stem cell banking market is expected to grow due to the increasing prevalence of such diseases and increasing awareness among people about the need to preserve stem cells. The umbilical cord blood of the newborn is an abundant source of stem cells. However, some tissues and organs within body, skin, blood, and the lining of intestine are also key source of tissue-specific stem cells. The stem cells are separated from the blood or tissue, processed, tested and preserved in a stem cell bank.



Stem cell banking has application in the treatment of cerebral palsy, thalassemia, leukemia, diabetes, autism, and others. In particular, the prevalence of diseases such as leukemia is increasing on a tremendous rate, thereby leading to an increase in the demand for stem cell banking. According to Leukemia and Lymphoma Society (LLS), a voluntary health organization engaged in funding research and ensuring access to treatments for blood cancer patients, approximately every 3 minutes one person in the U.S. is diagnosed with a blood cancer. An estimated combined total of 172,910 people in the U.S. are expected to be diagnosed with leukemia, lymphoma or myeloma in 2017, also new cases of leukemia, lymphoma and myeloma are expected to account for 10.2% of the estimated 1,688,780 new cancer cases diagnosed in the U.S., in 2017.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=stem-cell-banking-market

North America holds the largest share in the global stem cell banking market since the majority of stem cell banking players are based in the region. The growth in the North American stem cell banking industry is mainly due to the increase in awareness among people regarding stem cell banks.

Some of the major players operating in the stem cell banking market include Cordlife Group Ltd, Cryocell International, Inc., Lifecell International Pvt. Ltd., PerkinElmer, Inc. (Viacord), StemCyte Inc., CryoSave AG, China Cord Blood Corporation, Cord Blood America, Inc., Caladrius Biosciences Inc., CBR Systems, Inc., Cordvida, Cordviva India.

Genetic Testing Market Will Make a Huge Impact in Near Future

The global genetic testing market is projected to grow considerably in the coming years, due to the growing number of test to study multiple genes that may help in managing individual health condition. Additionally, the government initiatives to spread awareness with respect to the advantages of procedure is further expected to drive the growth of the market. The market is categorized into carrier testing, diagnostic testing, new-born screening, predictive & pre-symptomatic testing, prenatal testing, based on types of gene testing. Among the various types, new born screening held the largest share in 2016, due to the growing number of newborn genetic screening programs, while carrier testing is expected to project the fastest growth in demand during the forecast period.



North America was the largest contributor to the market in 2016. According to the NCBI repository that maintains Genetic Testing Registry(GTR)data from 505 lab participants worldwide, the U.S. leads with 259 labs contributions. Some of the key factors leading to the growth of the market in the region are the presence of large number of academic and research institutes, rising government funding, and availability of technologically advanced products. However, Asia-Pacific is expected to witness the fastest growth in the genetic testing market during the forecast period. The major factors driving the region’s growth include increasing awareness about the advantages of predictive testing, and rise in the adoption of advanced technology for clinical applications.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/genetic-testing-market/report-sample

Genetic tests in conjugation with other genomic technologies would help predict the risk of an individual to a disease and is also expected to assist clinicians to select suitable therapeutic interventions. These factors also increase the opportunities for players in pharmaceutical industry to grow, by providing treatment options to their end users. For instance, 23andMe offers direct genetic makeup tests to the consumers and based on the results of tests, the company recommends genetic counsellors to help the consumers about the better testing of genes, and the inherited diseases.

Major players in the genetic testing market are Transgenomic, Inc., GE Healthcare, 23 & Me Sequenom, Inc., Abbott Laboratories, Biocartis SA, Illumina Inc., 454 Life Sciences, Bio-Rad Laboratories, Luminex Corporation, Affymetrix Inc., Agilent Technologies Inc., Cephide Inc., Beckman Coulter Inc.